Catheter PrecisionFRA:4RM 23 PS Ratio is 144.96 as of Jul. 08, 2026, which is 1998% above its 10-year median of 6.91. GuruFocus rates FRA:4RM with a GF Score™ of 23/100 and a GF Value™ of €242.07. The stock has 7 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Catheter Precision ranks better than 82.84% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Catheter Precision's share price is €100.89.
Catheter Precision's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.70. Hence, Catheter Precision's PS Ratio for today is 144.96.
Good Sign:
Catheter Precision Inc stock PS Ratio (=0.88) is close to 1-year low of 0.88.
The historical rank and industry rank for Catheter Precision's PS Ratio or its related term are showing as below:
FRA:4RM'
s PS Ratio Range Over the Past 10 Years
Min: 0.66 Med: 6.91 Max: 4982.22
Current: 0.88
During the past 10 years, Catheter Precision's highest PS Ratio was 4982.22. The lowest was 0.66. And the median was 6.91.
FRA:4RM's PS Ratio is ranked better than 82.84% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.935
vs FRA:4RM: 0.88
During the past 10 years, Catheter Precision's highest 3-Year average Revenue per Share Growth Rate was -35.30% per year. The lowest was -51.90% per year. And the median was -43.60% per year.
Back to Basics: PS Ratio
Catheter Precision (FRA:4RM) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Catheter Precision PS Ratio Related Terms
Catheter Precision PS Ratio Historical Data
* Premium members only.
The historical data trend for Catheter Precision's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Catheter Precision's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's PS Ratio distribution charts can be found below:
* The bar in red indicates where Catheter Precision's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Catheter Precision's Share Price of today is €100.89. Catheter Precision's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.70.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Catheter Precision (FRA:4RM) has a PS Ratio of 144.96 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Catheter Precision and its competitors. This is 1998% above median its historical median of 6.91. Over the past decade, Catheter Precision's PS Ratio has ranged from 0.66 to 4,982.22. According to the industry distribution chart, Catheter Precision ranks #138 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 17.2%.
Is Catheter Precision's PS Ratio too high?
Catheter Precision's current PS Ratio of 144.96 is 1998% above median its 10-year median of 6.91. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 4,982.22. The Medical Devices & Instruments industry median PS Ratio is 2.94. Catheter Precision's value of 144.96 is 4839% above this industry median. Based on the distribution chart, Catheter Precision ranks #138 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Catheter Precision has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's PS Ratio compare to ALURD and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #138 out of 804 companies for PS Ratio. This places Catheter Precision in the top 17% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.94. Catheter Precision's value of 144.96 is 4839% above this benchmark. Historically, Catheter Precision's own PS Ratio has ranged from 0.66 to 4,982.22 over the past decade. While the company's 10-year median is 6.91 vs. the industry median of 2.94, Catheter Precision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Catheter Precision's current PS Ratio of 144.96 is 4839% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current PS Ratio is 144.96, which is 1998% above median its own 10-year median of 6.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current PS Ratio of 144.96. The stock's GF Value™ is €242.07, compared to a current price of €100.89 — trading 58.3% below its estimated fair value. The current PS Ratio is 144.96, which is 1998% above median its 10-year median of 6.91 and 4839% above the Medical Devices & Instruments industry median of 2.94. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current PS Ratio is 144.96 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (FRA:4RM) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of €100.89 is trading 58.3% below its estimated GF Value™ of €242.07.
Key valuation signals for FRA:4RM:
PS Ratio: 144.96 (1998% above median its 10-year median of 6.91)
GF Value™: €242.07 vs. price of €100.89 (58.3% below fair value)
Industry Position: 4839% above the Medical Devices & Instruments median (#138 of 804)
No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score
Get the complete analysis for FRA:4RM
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4RM has been successfully added to your 
